Connection
David Kao to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications David Kao has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.915 |
|
|
|
-
Kao DP, Martin JL, Aquilante CL, Shalowitz EL, Leyba K, Kudron E, Reusch JEB, Regensteiner JG. Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration. BMJ Open Diabetes Res Care. 2024 Dec 05; 12(6).
Score: 0.690
-
Kao DP, Kohrt HE, Kugler J. Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. Diabet Med. 2008 Oct; 25(10):1229-30.
Score: 0.225